These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 38902779)

  • 1. The role of RNA methylation in tumor immunity and its potential in immunotherapy.
    Li Y; Jin H; Li Q; Shi L; Mao Y; Zhao L
    Mol Cancer; 2024 Jun; 23(1):130. PubMed ID: 38902779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Writers, readers, and erasers RNA modifications and drug resistance in cancer.
    Chen D; Gu X; Nurzat Y; Xu L; Li X; Wu L; Jiao H; Gao P; Zhu X; Yan D; Li S; Xue C
    Mol Cancer; 2024 Aug; 23(1):178. PubMed ID: 39215288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy.
    Guo L; Yang H; Zhou C; Shi Y; Huang L; Zhang J
    Front Immunol; 2021; 12():773570. PubMed ID: 34956201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into the regulatory role of RNA methylation modifications in glioma.
    Long S; Yan Y; Xu H; Wang L; Jiang J; Xu Z; Liu R; Zhou Q; Huang X; Chen J; Li Z; Wei W; Li X
    J Transl Med; 2023 Nov; 21(1):810. PubMed ID: 37964279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of RNA methylation modification patterns mediated by m7G, m6A, m5C and m1A regulators in immune microenvironment regulation of Sjögren's syndrome.
    Liu Y; Zhu J; Ding L
    Cell Signal; 2023 Jun; 106():110650. PubMed ID: 36935085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA methylation: A potential therapeutic target in autoimmune disease.
    Li L; Xia X; Yang T; Sun Y; Liu X; Xu W; Lu M; Cui D; Wu Y
    Int Rev Immunol; 2024 May; 43(3):160-177. PubMed ID: 37975549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The functions and mechanisms of post-translational modification in protein regulators of RNA methylation: Current status and future perspectives.
    Chen Y; Jiang Z; Yang Y; Zhang C; Liu H; Wan J
    Int J Biol Macromol; 2023 Dec; 253(Pt 2):126773. PubMed ID: 37690652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular structure and biological functions of RNA methylation, with special emphasis on the roles of RNA methylation in autoimmune diseases.
    Zhou W; Wang X; Chang J; Cheng C; Miao C
    Crit Rev Clin Lab Sci; 2022 May; 59(3):203-218. PubMed ID: 34775884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential regulatory role of RNA methylation in ovarian cancer.
    Zhao S; Zhang M; Zhu X; Xing J; Zhou J; Yin X
    RNA Biol; 2023 Jan; 20(1):207-218. PubMed ID: 37194218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unravelling the impact of RNA methylation genetic and epigenetic machinery in the treatment of cardiomyopathy.
    Liu L; Yu L; Wang Y; Zhou L; Liu Y; Pan X; Huang J
    Pharmacol Res; 2024 Sep; 207():107305. PubMed ID: 39002868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging roles of RNA methylation in gastrointestinal cancers.
    Xie S; Chen W; Chen K; Chang Y; Yang F; Lin A; Shu Q; Zhou T; Yan X
    Cancer Cell Int; 2020 Dec; 20(1):585. PubMed ID: 33372610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manipulating the tumour immune microenvironment by N6-methyladenosine RNA modification.
    Sun X; Wang H; Pu X; Wu Y; Yuan X; Wang X; Lu H
    Cancer Gene Ther; 2024 Sep; 31(9):1315-1322. PubMed ID: 38834772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic RNA methylation modifications and their regulatory role in mammalian development and diseases.
    Yang W; Zhao Y; Yang Y
    Sci China Life Sci; 2024 Oct; 67(10):2084-2104. PubMed ID: 38833084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging function of main RNA methylation modifications in the immune microenvironment of digestive system tumors.
    Zeng Y; Yu T; Lou Z; Chen L; Pan L; Ruan B
    Pathol Res Pract; 2024 Apr; 256():155268. PubMed ID: 38547773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An m6A/m5C/m1A/m7G-Related Long Non-coding RNA Signature to Predict Prognosis and Immune Features of Glioma.
    Shao D; Li Y; Wu J; Zhang B; Xie S; Zheng X; Jiang Z
    Front Genet; 2022; 13():903117. PubMed ID: 35692827
    [No Abstract]   [Full Text] [Related]  

  • 16. m6A modification of RNA in cervical cancer: role and clinical perspectives.
    Gao Y; Guo Q; Yu L
    RNA Biol; 2024 Jan; 21(1):49-61. PubMed ID: 39344658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of RNA modification in hepatocellular carcinoma.
    Feng Q; Wang D; Xue T; Lin C; Gao Y; Sun L; Jin Y; Liu D
    Front Pharmacol; 2022; 13():984453. PubMed ID: 36120301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of m
    Wu C; Li L; Tang Q; Liao Q; Chen P; Guo C; Zeng Z; Xiong W
    Med Oncol; 2024 May; 41(6):159. PubMed ID: 38761335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulations of m
    Chen XH; Guo KX; Li J; Xu SH; Zhu H; Yan GR
    Front Med; 2024 Aug; 18(4):622-648. PubMed ID: 38907157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. M7G-related tumor immunity: novel insights of RNA modification and potential therapeutic targets.
    Han M; Huang Q; Li X; Chen X; Zhu H; Pan Y; Zhang B
    Int J Biol Sci; 2024; 20(4):1238-1255. PubMed ID: 38385078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.